International regulators provide guiding principles for COVID-19 clinical trials

1 July 2020 - EMA has endorsed a joint statement on prioritisation of COVID-19 clinical trials published by the International ...

Read more →

Medicines Australia welcomes support for national harmonisation of clinical trials

30 June 2020 - Medicines Australia welcomes the announcement from the Minister for Health, the Hon Greg Hunt MP, during ...

Read more →

Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines

24 June 2020 - Under the umbrella of the International Coalition of Medicines Regulatory Authorities, international regulators discussed COVID-19 vaccine ...

Read more →

Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests

18 June 2020 - For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for rising ...

Read more →

First drug proves able to improve survival from COVID-19, trial shows

17 June 2020 - A low-cost, widely used anti-inflammatory drug has improved survival in patients with COVID-19, scientists say, the ...

Read more →

The Lancet, New England Journal retract COVID-19 studies, including one that raised safety concerns about malaria drugs

4 June 2020 - The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study that ...

Read more →

WHO set to resume hydroxychloroquine trial in battle against COVID-19

4 June 2020 - The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its ...

Read more →

Malaria drug promoted by Trump did not prevent COVID-19 infections, study finds

3 June 2020 - The first carefully controlled trial of hydroxychloroquine given to people exposed to the coronavirus did not show ...

Read more →

EMA weighs COVID-19 data transparency, not ready to resume full clinical data publication

1 June 2020 - In a response to officials at Germany’s IQWiG and the Cochrane Collaboration, EMA Executive Director Guido ...

Read more →

COVID-19: researchers halt patient recruitment for hydroxychloroquine trial

28 May 2020 - Australian researchers have suspended patient recruitment in a major clinical trial of the controversial anti-malaria drug ...

Read more →

WHO pauses hydroxycholoroquine arm in COVID-19 trial

26 May 2020 - The World Health Organisation has announced a temporary pause on a clinical trial arm testing hydroxycholoroquine ...

Read more →

EMA calls for high-quality observational research in context of COVID-19

26 May 2020 - For observational studies of real world data in COVID-19, EMA calls for transparency for protocols and results, ...

Read more →

Australians stick with malaria drug hydroxychoroquine trial

26 May 2020 - Australian researchers are pressing ahead with administering the controversial antimalarial drug hydroxychloroquine in at least one ...

Read more →

WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

26 May 2020 - The World Health Organisation has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to ...

Read more →

International coordination needed to encourage conduct of large, decision-relevant COVID-19 clinical trials

15 May 2020 - Regulators are highlighting the need for a comprehensive international coordination mechanism to allow the conduct of ...

Read more →